Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction‐associated steatotic liver disease: Post hoc analysis of three randomised controlled trials

  • Matthew J. Armstrong*
  • , Takeshi Okanoue
  • , Mads Sundby Palle
  • , Anne‐Sophie Sejling
  • , Mohamed Tawfik
  • , Michael Roden
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction‐associated steatotic liver disease: Post hoc analysis of three randomised controlled trials'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Food Science